Tranexamic acid in trauma: After 3 hours from injury, when is it safe and effective to use again? Article Swipe
Christopher D. Barrett
,
Matthew D. Neal
,
Jonathan G. Schoenecker
,
Robert L. Medcalf
,
Paul S. Myles
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1111/trf.17779
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1111/trf.17779
Tranexamic acid (TXA) has proven mortality benefit if used early after traumatic injury, likely related to a combination of bleeding reduction and other non‐bleeding effects. If TXA is given more than 3 h after traumatic injury, there is a significant and paradoxical increased risk of death due to bleeding. TXA has level 1 evidence for use as a bleeding reduction agent in isolated orthopedic operations, but in polytrauma patients undergoing orthopedic operations, it is not clear if and when TXA is safe or effective once outside the 3‐h window of proven trauma efficacy.
Related Topics
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1111/trf.17779
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/trf.17779
- OA Status
- hybrid
- Cited By
- 6
- References
- 12
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4392629663
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4392629663Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1111/trf.17779Digital Object Identifier
- Title
-
Tranexamic acid in trauma: After 3 hours from injury, when is it safe and effective to use again?Work title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-03-10Full publication date if available
- Authors
-
Christopher D. Barrett, Matthew D. Neal, Jonathan G. Schoenecker, Robert L. Medcalf, Paul S. MylesList of authors in order
- Landing page
-
https://doi.org/10.1111/trf.17779Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/trf.17779Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/trf.17779Direct OA link when available
- Concepts
-
Tranexamic acid, Polytrauma, Medicine, Orthopedic surgery, Surgery, Anesthesia, Blood lossTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
6Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 5, 2024: 1Per-year citation counts (last 5 years)
- References (count)
-
12Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4392629663 |
|---|---|
| doi | https://doi.org/10.1111/trf.17779 |
| ids.doi | https://doi.org/10.1111/trf.17779 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38461482 |
| ids.openalex | https://openalex.org/W4392629663 |
| fwci | 5.8047096 |
| mesh[0].qualifier_ui | Q000627 |
| mesh[0].descriptor_ui | D014148 |
| mesh[0].is_major_topic | True |
| mesh[0].qualifier_name | therapeutic use |
| mesh[0].descriptor_name | Tranexamic Acid |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006801 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Humans |
| mesh[2].qualifier_ui | Q000150 |
| mesh[2].descriptor_ui | D014947 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | complications |
| mesh[2].descriptor_name | Wounds and Injuries |
| mesh[3].qualifier_ui | Q000188 |
| mesh[3].descriptor_ui | D014947 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | drug therapy |
| mesh[3].descriptor_name | Wounds and Injuries |
| mesh[4].qualifier_ui | Q000627 |
| mesh[4].descriptor_ui | D000933 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | therapeutic use |
| mesh[4].descriptor_name | Antifibrinolytic Agents |
| mesh[5].qualifier_ui | Q000009 |
| mesh[5].descriptor_ui | D000933 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | adverse effects |
| mesh[5].descriptor_name | Antifibrinolytic Agents |
| mesh[6].qualifier_ui | Q000188 |
| mesh[6].descriptor_ui | D006470 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | drug therapy |
| mesh[6].descriptor_name | Hemorrhage |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D013997 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Time Factors |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D009104 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Multiple Trauma |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D006801 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Humans |
| mesh[10].qualifier_ui | Q000008 |
| mesh[10].descriptor_ui | D000933 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | administration & dosage |
| mesh[10].descriptor_name | Antifibrinolytic Agents |
| mesh[11].qualifier_ui | Q000009 |
| mesh[11].descriptor_ui | D000933 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | adverse effects |
| mesh[11].descriptor_name | Antifibrinolytic Agents |
| mesh[12].qualifier_ui | Q000188 |
| mesh[12].descriptor_ui | D006470 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | drug therapy |
| mesh[12].descriptor_name | Hemorrhage |
| mesh[13].qualifier_ui | Q000209 |
| mesh[13].descriptor_ui | D006470 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | etiology |
| mesh[13].descriptor_name | Hemorrhage |
| mesh[14].qualifier_ui | Q000150 |
| mesh[14].descriptor_ui | D009104 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | complications |
| mesh[14].descriptor_name | Multiple Trauma |
| mesh[15].qualifier_ui | Q000188 |
| mesh[15].descriptor_ui | D009104 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | drug therapy |
| mesh[15].descriptor_name | Multiple Trauma |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D013997 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Time Factors |
| mesh[17].qualifier_ui | Q000008 |
| mesh[17].descriptor_ui | D014148 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | administration & dosage |
| mesh[17].descriptor_name | Tranexamic Acid |
| mesh[18].qualifier_ui | Q000009 |
| mesh[18].descriptor_ui | D014148 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | adverse effects |
| mesh[18].descriptor_name | Tranexamic Acid |
| mesh[19].qualifier_ui | Q000150 |
| mesh[19].descriptor_ui | D014947 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | complications |
| mesh[19].descriptor_name | Wounds and Injuries |
| mesh[20].qualifier_ui | Q000188 |
| mesh[20].descriptor_ui | D014947 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | drug therapy |
| mesh[20].descriptor_name | Wounds and Injuries |
| mesh[21].qualifier_ui | Q000627 |
| mesh[21].descriptor_ui | D014148 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | therapeutic use |
| mesh[21].descriptor_name | Tranexamic Acid |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D006801 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Humans |
| mesh[23].qualifier_ui | Q000150 |
| mesh[23].descriptor_ui | D014947 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | complications |
| mesh[23].descriptor_name | Wounds and Injuries |
| mesh[24].qualifier_ui | Q000188 |
| mesh[24].descriptor_ui | D014947 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | drug therapy |
| mesh[24].descriptor_name | Wounds and Injuries |
| mesh[25].qualifier_ui | Q000627 |
| mesh[25].descriptor_ui | D000933 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | therapeutic use |
| mesh[25].descriptor_name | Antifibrinolytic Agents |
| mesh[26].qualifier_ui | Q000009 |
| mesh[26].descriptor_ui | D000933 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | adverse effects |
| mesh[26].descriptor_name | Antifibrinolytic Agents |
| mesh[27].qualifier_ui | Q000188 |
| mesh[27].descriptor_ui | D006470 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | drug therapy |
| mesh[27].descriptor_name | Hemorrhage |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D013997 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Time Factors |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D009104 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Multiple Trauma |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D006801 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Humans |
| mesh[31].qualifier_ui | Q000008 |
| mesh[31].descriptor_ui | D000933 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | administration & dosage |
| mesh[31].descriptor_name | Antifibrinolytic Agents |
| mesh[32].qualifier_ui | Q000009 |
| mesh[32].descriptor_ui | D000933 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | adverse effects |
| mesh[32].descriptor_name | Antifibrinolytic Agents |
| mesh[33].qualifier_ui | Q000188 |
| mesh[33].descriptor_ui | D006470 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | drug therapy |
| mesh[33].descriptor_name | Hemorrhage |
| mesh[34].qualifier_ui | Q000209 |
| mesh[34].descriptor_ui | D006470 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | etiology |
| mesh[34].descriptor_name | Hemorrhage |
| mesh[35].qualifier_ui | Q000150 |
| mesh[35].descriptor_ui | D009104 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | complications |
| mesh[35].descriptor_name | Multiple Trauma |
| mesh[36].qualifier_ui | Q000188 |
| mesh[36].descriptor_ui | D009104 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | drug therapy |
| mesh[36].descriptor_name | Multiple Trauma |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D013997 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Time Factors |
| mesh[38].qualifier_ui | Q000008 |
| mesh[38].descriptor_ui | D014148 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | administration & dosage |
| mesh[38].descriptor_name | Tranexamic Acid |
| mesh[39].qualifier_ui | Q000009 |
| mesh[39].descriptor_ui | D014148 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | adverse effects |
| mesh[39].descriptor_name | Tranexamic Acid |
| mesh[40].qualifier_ui | Q000150 |
| mesh[40].descriptor_ui | D014947 |
| mesh[40].is_major_topic | True |
| mesh[40].qualifier_name | complications |
| mesh[40].descriptor_name | Wounds and Injuries |
| mesh[41].qualifier_ui | Q000188 |
| mesh[41].descriptor_ui | D014947 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | drug therapy |
| mesh[41].descriptor_name | Wounds and Injuries |
| type | review |
| title | Tranexamic acid in trauma: After 3 hours from injury, when is it safe and effective to use again? |
| biblio.issue | S2 |
| biblio.volume | 64 |
| biblio.last_page | S13 |
| biblio.first_page | S11 |
| topics[0].id | https://openalex.org/T11116 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2706 |
| topics[0].subfield.display_name | Critical Care and Intensive Care Medicine |
| topics[0].display_name | Trauma, Hemostasis, Coagulopathy, Resuscitation |
| topics[1].id | https://openalex.org/T11467 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9986000061035156 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2711 |
| topics[1].subfield.display_name | Emergency Medicine |
| topics[1].display_name | Trauma and Emergency Care Studies |
| topics[2].id | https://openalex.org/T10693 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9958000183105469 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2704 |
| topics[2].subfield.display_name | Biochemistry |
| topics[2].display_name | Blood transfusion and management |
| funders[0].id | https://openalex.org/F4320309052 |
| funders[0].ror | https://ror.org/031ywxc85 |
| funders[0].display_name | Alexion Pharmaceuticals |
| funders[1].id | https://openalex.org/F4320320971 |
| funders[1].ror | https://ror.org/02bfwt286 |
| funders[1].display_name | Monash University |
| funders[2].id | https://openalex.org/F4320332193 |
| funders[2].ror | https://ror.org/04gndp242 |
| funders[2].display_name | Genentech |
| is_xpac | False |
| apc_list.value | 3900 |
| apc_list.currency | USD |
| apc_list.value_usd | 3900 |
| apc_paid.value | 3900 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3900 |
| concepts[0].id | https://openalex.org/C2779637338 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9814523458480835 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q418666 |
| concepts[0].display_name | Tranexamic acid |
| concepts[1].id | https://openalex.org/C2776692886 |
| concepts[1].level | 2 |
| concepts[1].score | 0.9235914945602417 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q2103168 |
| concepts[1].display_name | Polytrauma |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.8969347476959229 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C68312169 |
| concepts[3].level | 2 |
| concepts[3].score | 0.684714674949646 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q216685 |
| concepts[3].display_name | Orthopedic surgery |
| concepts[4].id | https://openalex.org/C141071460 |
| concepts[4].level | 1 |
| concepts[4].score | 0.4471144378185272 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[4].display_name | Surgery |
| concepts[5].id | https://openalex.org/C42219234 |
| concepts[5].level | 1 |
| concepts[5].score | 0.4372172951698303 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q131130 |
| concepts[5].display_name | Anesthesia |
| concepts[6].id | https://openalex.org/C2991743468 |
| concepts[6].level | 2 |
| concepts[6].score | 0.20589852333068848 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q166019 |
| concepts[6].display_name | Blood loss |
| keywords[0].id | https://openalex.org/keywords/tranexamic-acid |
| keywords[0].score | 0.9814523458480835 |
| keywords[0].display_name | Tranexamic acid |
| keywords[1].id | https://openalex.org/keywords/polytrauma |
| keywords[1].score | 0.9235914945602417 |
| keywords[1].display_name | Polytrauma |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.8969347476959229 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/orthopedic-surgery |
| keywords[3].score | 0.684714674949646 |
| keywords[3].display_name | Orthopedic surgery |
| keywords[4].id | https://openalex.org/keywords/surgery |
| keywords[4].score | 0.4471144378185272 |
| keywords[4].display_name | Surgery |
| keywords[5].id | https://openalex.org/keywords/anesthesia |
| keywords[5].score | 0.4372172951698303 |
| keywords[5].display_name | Anesthesia |
| keywords[6].id | https://openalex.org/keywords/blood-loss |
| keywords[6].score | 0.20589852333068848 |
| keywords[6].display_name | Blood loss |
| language | en |
| locations[0].id | doi:10.1111/trf.17779 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S186746772 |
| locations[0].source.issn | 0041-1132, 1537-2995 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0041-1132 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Transfusion |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_lineage_names | Wiley |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/trf.17779 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Transfusion |
| locations[0].landing_page_url | https://doi.org/10.1111/trf.17779 |
| locations[1].id | pmid:38461482 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Transfusion |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38461482 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5004607212 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-9720-8155 |
| authorships[0].author.display_name | Christopher D. Barrett |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I59130452 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska, USA |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I59130452 |
| authorships[0].affiliations[1].raw_affiliation_string | Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska, USA |
| authorships[0].institutions[0].id | https://openalex.org/I59130452 |
| authorships[0].institutions[0].ror | https://ror.org/00thqtb16 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I59130452 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | University of Nebraska Medical Center |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Christopher D. Barrett |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska, USA, Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska, USA |
| authorships[1].author.id | https://openalex.org/A5029058133 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-8931-6236 |
| authorships[1].author.display_name | Matthew D. Neal |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210134769 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA |
| authorships[1].institutions[0].id | https://openalex.org/I4210134769 |
| authorships[1].institutions[0].ror | https://ror.org/04ehecz88 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210098814, https://openalex.org/I4210134769 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | University of Pittsburgh Medical Center |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Matthew D. Neal |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA |
| authorships[2].author.id | https://openalex.org/A5022984651 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-3097-5496 |
| authorships[2].author.display_name | Jonathan G. Schoenecker |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I901861585 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA |
| authorships[2].institutions[0].id | https://openalex.org/I901861585 |
| authorships[2].institutions[0].ror | https://ror.org/05dq2gs74 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210162197, https://openalex.org/I901861585 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Vanderbilt University Medical Center |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Jonathan G. Schoenecker |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA |
| authorships[3].author.id | https://openalex.org/A5084027827 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-6885-3892 |
| authorships[3].author.display_name | Robert L. Medcalf |
| authorships[3].countries | AU |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210128357, https://openalex.org/I56590836 |
| authorships[3].affiliations[0].raw_affiliation_string | Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia |
| authorships[3].institutions[0].id | https://openalex.org/I4210128357 |
| authorships[3].institutions[0].ror | https://ror.org/02he67h29 |
| authorships[3].institutions[0].type | facility |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210128357 |
| authorships[3].institutions[0].country_code | AU |
| authorships[3].institutions[0].display_name | Australian Centre for HIV and Hepatitis Virology Research |
| authorships[3].institutions[1].id | https://openalex.org/I56590836 |
| authorships[3].institutions[1].ror | https://ror.org/02bfwt286 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I56590836 |
| authorships[3].institutions[1].country_code | AU |
| authorships[3].institutions[1].display_name | Monash University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Robert L. Medcalf |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia |
| authorships[4].author.id | https://openalex.org/A5025692427 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-3324-5456 |
| authorships[4].author.display_name | Paul S. Myles |
| authorships[4].countries | AU |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I56590836 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Anaesthesiology and Perioperative Medicine, Alfred Hospital and Monash University, Melbourne, Victoria, Australia |
| authorships[4].institutions[0].id | https://openalex.org/I56590836 |
| authorships[4].institutions[0].ror | https://ror.org/02bfwt286 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I56590836 |
| authorships[4].institutions[0].country_code | AU |
| authorships[4].institutions[0].display_name | Monash University |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Paul S. Myles |
| authorships[4].is_corresponding | True |
| authorships[4].raw_affiliation_strings | Department of Anaesthesiology and Perioperative Medicine, Alfred Hospital and Monash University, Melbourne, Victoria, Australia |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/trf.17779 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Tranexamic acid in trauma: After 3 hours from injury, when is it safe and effective to use again? |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11116 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2706 |
| primary_topic.subfield.display_name | Critical Care and Intensive Care Medicine |
| primary_topic.display_name | Trauma, Hemostasis, Coagulopathy, Resuscitation |
| related_works | https://openalex.org/W3118036361, https://openalex.org/W3045868972, https://openalex.org/W2118188452, https://openalex.org/W2121932716, https://openalex.org/W2376074389, https://openalex.org/W2810834227, https://openalex.org/W4214875478, https://openalex.org/W3122470092, https://openalex.org/W2109529210, https://openalex.org/W2391187917 |
| cited_by_count | 6 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 5 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1111/trf.17779 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S186746772 |
| best_oa_location.source.issn | 0041-1132, 1537-2995 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0041-1132 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Transfusion |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_lineage_names | Wiley |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/trf.17779 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Transfusion |
| best_oa_location.landing_page_url | https://doi.org/10.1111/trf.17779 |
| primary_location.id | doi:10.1111/trf.17779 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S186746772 |
| primary_location.source.issn | 0041-1132, 1537-2995 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0041-1132 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Transfusion |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_lineage_names | Wiley |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/trf.17779 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Transfusion |
| primary_location.landing_page_url | https://doi.org/10.1111/trf.17779 |
| publication_date | 2024-03-10 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2333297405, https://openalex.org/W2162249417, https://openalex.org/W3090703731, https://openalex.org/W2621421374, https://openalex.org/W2588683575, https://openalex.org/W2034226877, https://openalex.org/W1939149497, https://openalex.org/W1987604733, https://openalex.org/W2899288620, https://openalex.org/W3011836431, https://openalex.org/W2525398138, https://openalex.org/W2946701161 |
| referenced_works_count | 12 |
| abstract_inverted_index.1 | 53 |
| abstract_inverted_index.3 | 32 |
| abstract_inverted_index.a | 17, 39, 58 |
| abstract_inverted_index.h | 33 |
| abstract_inverted_index.If | 26 |
| abstract_inverted_index.as | 57 |
| abstract_inverted_index.if | 8, 77 |
| abstract_inverted_index.in | 62, 67 |
| abstract_inverted_index.is | 28, 38, 74, 81 |
| abstract_inverted_index.it | 73 |
| abstract_inverted_index.of | 19, 45, 90 |
| abstract_inverted_index.or | 83 |
| abstract_inverted_index.to | 16, 48 |
| abstract_inverted_index.TXA | 27, 50, 80 |
| abstract_inverted_index.and | 22, 41, 78 |
| abstract_inverted_index.but | 66 |
| abstract_inverted_index.due | 47 |
| abstract_inverted_index.for | 55 |
| abstract_inverted_index.has | 4, 51 |
| abstract_inverted_index.not | 75 |
| abstract_inverted_index.the | 87 |
| abstract_inverted_index.use | 56 |
| abstract_inverted_index.acid | 2 |
| abstract_inverted_index.more | 30 |
| abstract_inverted_index.once | 85 |
| abstract_inverted_index.risk | 44 |
| abstract_inverted_index.safe | 82 |
| abstract_inverted_index.than | 31 |
| abstract_inverted_index.used | 9 |
| abstract_inverted_index.when | 79 |
| abstract_inverted_index.(TXA) | 3 |
| abstract_inverted_index.3‐h | 88 |
| abstract_inverted_index.after | 11, 34 |
| abstract_inverted_index.agent | 61 |
| abstract_inverted_index.clear | 76 |
| abstract_inverted_index.death | 46 |
| abstract_inverted_index.early | 10 |
| abstract_inverted_index.given | 29 |
| abstract_inverted_index.level | 52 |
| abstract_inverted_index.other | 23 |
| abstract_inverted_index.there | 37 |
| abstract_inverted_index.likely | 14 |
| abstract_inverted_index.proven | 5, 91 |
| abstract_inverted_index.trauma | 92 |
| abstract_inverted_index.window | 89 |
| abstract_inverted_index.benefit | 7 |
| abstract_inverted_index.injury, | 13, 36 |
| abstract_inverted_index.outside | 86 |
| abstract_inverted_index.related | 15 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.bleeding | 20, 59 |
| abstract_inverted_index.effects. | 25 |
| abstract_inverted_index.evidence | 54 |
| abstract_inverted_index.isolated | 63 |
| abstract_inverted_index.patients | 69 |
| abstract_inverted_index.bleeding. | 49 |
| abstract_inverted_index.effective | 84 |
| abstract_inverted_index.efficacy. | 93 |
| abstract_inverted_index.increased | 43 |
| abstract_inverted_index.mortality | 6 |
| abstract_inverted_index.reduction | 21, 60 |
| abstract_inverted_index.traumatic | 12, 35 |
| abstract_inverted_index.Tranexamic | 1 |
| abstract_inverted_index.orthopedic | 64, 71 |
| abstract_inverted_index.polytrauma | 68 |
| abstract_inverted_index.undergoing | 70 |
| abstract_inverted_index.combination | 18 |
| abstract_inverted_index.operations, | 65, 72 |
| abstract_inverted_index.paradoxical | 42 |
| abstract_inverted_index.significant | 40 |
| abstract_inverted_index.non‐bleeding | 24 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 90 |
| corresponding_author_ids | https://openalex.org/A5025692427 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 5 |
| corresponding_institution_ids | https://openalex.org/I56590836 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8700000047683716 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.91676743 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |